In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin

Citation
A. Gikas et al., In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin, ANTIM AG CH, 45(11), 2001, pp. 3276-3278
Citations number
22
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
45
Issue
11
Year of publication
2001
Pages
3276 - 3278
Database
ISI
SICI code
0066-4804(200111)45:11<3276:IVSOCB>2.0.ZU;2-O
Abstract
The in vitro susceptibility to linezolid shown by nine Greek isolates of Co xiella burnetii derived from patients with acute Q fever was investigated. MICs of linezolid were compared with those of pefloxacin, ciprofloxacin, of loxacin, trovafloxacin, doxycycline, and clarithromycin using the shell via l assay. MICs of linezolid and clarithromycin ranged from 2 to 4 mug/ml; th ose of doxycycline, trovafloxacin, and ofloxacin ranged from 1 to 2 mug/ml; those of pefloxacin ranged from 1 to 4 mug/ml; and those of ciprofloxacin ranged from 4 to 8 mug/ml. Linezolid was effective in controlling intracell ular parasites in cultures of Vero cells infected by C. burnetii. No bacter icidal activity by linezolid was obtained against C. burnetii at 8 mug/ml.